2021 Meeting

ADHD in the Era of COVID: Maintaining Focus”

The 2021 APSARD Annual Meeting will be held virtually January 15-17, 2021.

For more information on the meeting click here for the official conference website.

The APSARD Annual Meeting is an important venue for the presentation of critical information on ADHD and Related Disorders including appropriate diagnosis and assessment, current, as well as emerging, treatment paradigms and updates in science and technology advances.  It is known as a meeting which brings together multidisciplinary specialists in a collaborative atmosphere, to discuss practical, applied approaches to the management of ADHD in the real-world setting.

The 2021 Annual Meeting, January 15-17, 2021, will focus on the scientific basis of ADHD and its treatment, including tactics and approaches that support improved care and treatment of the patient with ADHD for the complex patient, college age patient, as well as ADHD in diverse populations. The meeting will provide clinicians with specific, practical information for appropriate diagnosis, assessment and treatment of ADHD in diverse setting and populations. Most importantly, the scientific basis that underlies the diagnostic and treatment approaches advocated will be highlighted.  We welcome your participation and support.


CONFERENCE LEARNING OBJECTIVES

  • The COVID-19 crisis has introduced major stressors for people with ADHD and its related disorders across many settings: home, school and the workplace. We seek submissions that will address the impact of COVID-19 on individuals and families with ADHD and which will present innovative methods of treatment that are useful during this pandemic. Submissions addressing how the pandemic will ultimately impact the care of people with ADHD are encouraged.

 

  • There are important ongoing dialogues in our country and worldwide regarding issues related to racism, racial disparities and related access to care. COVID-19 has disproportionately affected disadvantaged communities and people of color due to disparities in many social determinates of health. But these issues extend well beyond COVID-19, and pose important issues related to health care in general, and care of individuals and families with ADHD, in particular. APSARD seeks proposals that will address critical issues in this area.

CALL FOR SYMPOSIA AND POSTER ABSTRACTS

NEW THIS YEARSYMPOSIA AS WELL AS POSTER SUBMISSIONS WILL BE ACCEPTED

CALL FOR SYMPOSIA AND POSTER ABSTRACTS
SYMPOSIA DEADLINE:  Closed
POSTER DEADLINE: Monday, October 19, 2020

For the first time, APSARD is offering the opportunity for a limited number of symposia submissions to be accepted for oral presentation.  Poster submissions will continue to be accepted for review as usual.  Format requirements for both types of submissions are detailed below; all accepted presentations will be delivered online.

Submissions on topics of interest pertinent to ADHD and related disorders will be accepted, including but not limited to:

• Psychopathology and neurobiology
• Therapeutic interventions
• Assessment methods
• Public health and policy
• Etiology and outcomes

Consistent with the mission of APSARD, which is to bridge the gap between the basic and clinical sciences and their clinical application, submissions will be accepted based on a blend of one or more criteria: scientific rigor (data driven and evidence-based), significance, innovation, clarity, and current or ultimate application to clinical practice. Accepted presenters will be asked to prepare 1-3 “take-away” messages from their research with an emphasis on current or future clinical implications; basic science presentations may emphasize 1-3 “take-away” implication in lieu of messages on the findings accessible to a broad audience. We encourage submissions that consider topics from a variety of vantage points, include individuals from different disciplines and different institutions, and model diversity across the presenters.